vs

Side-by-side financial comparison of GRAIL, Inc. (GRAL) and SMITH MIDLAND CORP (SMID). Click either name above to swap in a different company.

GRAIL, Inc. is the larger business by last-quarter revenue ($43.6M vs $23.1M, roughly 1.9× SMITH MIDLAND CORP). SMITH MIDLAND CORP runs the higher net margin — 9.2% vs -227.5%, a 236.7% gap on every dollar of revenue. On growth, SMITH MIDLAND CORP posted the faster year-over-year revenue change (24.7% vs 14.0%). Over the past eight quarters, GRAIL, Inc.'s revenue compounded faster (27.7% CAGR vs 17.4%).

GRAIL, Inc. is an American biotechnology company based in Menlo Park, California founded in 2015 seeking to develop an early cancer screening test for people who do not have symptoms. As a startup it was a subsidiary of Illumina, which bought it outright in 2021.

Smith Midland Corp is a specialized manufacturer of precast concrete products for infrastructure, commercial, residential and industrial construction uses. Its key product lines include highway safety barriers, acoustic sound walls, architectural precast panels, and stormwater management systems, serving primarily the North American market with durable, sustainable construction solutions.

GRAL vs SMID — Head-to-Head

Bigger by revenue
GRAL
GRAL
1.9× larger
GRAL
$43.6M
$23.1M
SMID
Growing faster (revenue YoY)
SMID
SMID
+10.7% gap
SMID
24.7%
14.0%
GRAL
Higher net margin
SMID
SMID
236.7% more per $
SMID
9.2%
-227.5%
GRAL
Faster 2-yr revenue CAGR
GRAL
GRAL
Annualised
GRAL
27.7%
17.4%
SMID

Income Statement — Q4 FY2025 vs Q4 FY2025

Metric
GRAL
GRAL
SMID
SMID
Revenue
$43.6M
$23.1M
Net Profit
$-99.2M
$2.1M
Gross Margin
57.5%
Operating Margin
-285.4%
37.8%
Net Margin
-227.5%
9.2%
Revenue YoY
14.0%
24.7%
Net Profit YoY
-2.2%
52.5%
EPS (diluted)
$-2.37
$0.41

Green = leading value per metric. Periods may differ when fiscal calendars don't align.

8-Quarter Revenue & Profit Trend

Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.

Revenue
GRAL
GRAL
SMID
SMID
Q4 25
$43.6M
$23.1M
Q3 25
$36.2M
$21.5M
Q2 25
$35.5M
$26.2M
Q1 25
$31.8M
$22.7M
Q4 24
$38.3M
$18.5M
Q3 24
$28.7M
$23.6M
Q2 24
$32.0M
$19.6M
Q1 24
$26.7M
$16.8M
Net Profit
GRAL
GRAL
SMID
SMID
Q4 25
$-99.2M
$2.1M
Q3 25
$-89.0M
$2.9M
Q2 25
$-114.0M
$4.2M
Q1 25
$-106.2M
$3.3M
Q4 24
$-97.1M
$1.4M
Q3 24
$-125.7M
$3.1M
Q2 24
$-1.6B
$2.0M
Q1 24
$-218.9M
$1.1M
Gross Margin
GRAL
GRAL
SMID
SMID
Q4 25
57.5%
Q3 25
26.8%
Q2 25
0.0%
Q1 25
30.7%
Q4 24
51.4%
Q3 24
27.9%
Q2 24
0.0%
Q1 24
23.3%
Operating Margin
GRAL
GRAL
SMID
SMID
Q4 25
-285.4%
37.8%
Q3 25
-346.2%
18.0%
Q2 25
-446.9%
0.0%
Q1 25
-482.5%
19.3%
Q4 24
-358.0%
24.5%
Q3 24
-640.5%
16.3%
Q2 24
-5133.8%
0.0%
Q1 24
-851.1%
9.0%
Net Margin
GRAL
GRAL
SMID
SMID
Q4 25
-227.5%
9.2%
Q3 25
-245.8%
13.4%
Q2 25
-320.7%
15.9%
Q1 25
-333.6%
14.7%
Q4 24
-253.8%
7.5%
Q3 24
-438.7%
13.4%
Q2 24
-4958.8%
10.1%
Q1 24
-819.3%
6.8%
EPS (diluted)
GRAL
GRAL
SMID
SMID
Q4 25
$-2.37
$0.41
Q3 25
$-2.46
$0.54
Q2 25
$-3.18
$0.79
Q1 25
$-3.10
$0.62
Q4 24
$-1.49
$0.28
Q3 24
$-3.94
$0.59
Q2 24
$-51.06
$0.37
Q1 24
$-7.05
$0.21

Balance Sheet & Financial Strength

Snapshot of each company's liquidity, leverage and book value from the latest quarter.

Metric
GRAL
GRAL
SMID
SMID
Cash + ST InvestmentsLiquidity on hand
$249.7M
Total DebtLower is stronger
Stockholders' EquityBook value
$2.6B
$54.3M
Total Assets
$2.9B
$87.7M
Debt / EquityLower = less leverage

8-quarter trend — quarters aligned by calendar period.

Cash + ST Investments
GRAL
GRAL
SMID
SMID
Q4 25
$249.7M
Q3 25
$126.9M
Q2 25
$127.4M
Q1 25
$133.9M
Q4 24
$214.2M
Q3 24
$853.6M
Q2 24
$958.8M
Q1 24
$199.7M
Stockholders' Equity
GRAL
GRAL
SMID
SMID
Q4 25
$2.6B
$54.3M
Q3 25
$2.2B
$52.1M
Q2 25
$2.3B
$49.2M
Q1 25
$2.4B
$45.1M
Q4 24
$2.5B
$41.7M
Q3 24
$2.6B
$40.3M
Q2 24
$2.7B
$37.2M
Q1 24
$35.3M
Total Assets
GRAL
GRAL
SMID
SMID
Q4 25
$2.9B
$87.7M
Q3 25
$2.6B
$85.4M
Q2 25
$2.7B
$81.2K
Q1 25
$2.8B
$74.7M
Q4 24
$3.0B
$68.0M
Q3 24
$3.1B
$66.6M
Q2 24
$3.3B
$64.0M
Q1 24
$64.9M

Cash Flow & Capital Efficiency

How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.

Metric
GRAL
GRAL
SMID
SMID
Operating Cash FlowLast quarter
$-63.8M
Free Cash FlowOCF − Capex
$-63.9M
FCF MarginFCF / Revenue
-146.5%
Capex IntensityCapex / Revenue
0.2%
Cash ConversionOCF / Net Profit
TTM Free Cash FlowTrailing 4 quarters
$-299.9M

8-quarter trend — quarters aligned by calendar period.

Operating Cash Flow
GRAL
GRAL
SMID
SMID
Q4 25
$-63.8M
Q3 25
$-63.2M
$11.7M
Q2 25
$-77.0M
Q1 25
$-95.0M
$2.2M
Q4 24
$-645.0K
Q3 24
$-104.6M
$3.9M
Q2 24
$-171.8M
$2.7M
Q1 24
$-207.3M
$-777.0K
Free Cash Flow
GRAL
GRAL
SMID
SMID
Q4 25
$-63.9M
Q3 25
$-63.6M
$6.3M
Q2 25
$-77.3M
Q1 25
$-95.1M
$1.6M
Q4 24
$-1.3M
Q3 24
$-105.6M
$1.8M
Q2 24
$-173.2M
$998.0K
Q1 24
$-209.8M
$-2.6M
FCF Margin
GRAL
GRAL
SMID
SMID
Q4 25
-146.5%
Q3 25
-175.8%
29.5%
Q2 25
-217.6%
Q1 25
-298.6%
7.1%
Q4 24
-7.0%
Q3 24
-368.4%
7.8%
Q2 24
-541.7%
5.1%
Q1 24
-785.3%
-15.3%
Capex Intensity
GRAL
GRAL
SMID
SMID
Q4 25
0.2%
Q3 25
1.1%
25.1%
Q2 25
1.0%
Q1 25
0.2%
2.6%
Q4 24
3.6%
Q3 24
3.4%
8.6%
Q2 24
4.3%
8.7%
Q1 24
9.5%
10.7%
Cash Conversion
GRAL
GRAL
SMID
SMID
Q4 25
Q3 25
4.07×
Q2 25
Q1 25
0.67×
Q4 24
-0.46×
Q3 24
1.23×
Q2 24
1.37×
Q1 24
-0.68×

Financial Flow Comparison

Revenue → gross profit → operating profit → net profit for each company.

Revenue Breakdown by Segment

GRAL
GRAL

Screening Revenue$42.3M97%
Developmental Services Revenue$1.3M3%

SMID
SMID

Product Sales$13.8M60%
Service Revenue$9.3M40%

Related Comparisons